Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
ARGX
ARGX News & Events
-
Add to Watchlist
Trade ARGX
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
ARGX Stock News Today | Earnings, Events & Price Alerts
ARGX News
Significant Milestones in Biotech Sector This Week
3d ago
NASDAQ.COM
Argenx Reports Strong Q4 Results and Positive Phase 3 Study Outcomes
3d ago
Benzinga
Argenx Reports Positive Phase 3 Results for VYVGART in Ocular Myasthenia Gravis
4d ago
Benzinga
Argenx Reports Positive Phase 3 Results for Vyvgart in Eye Disease
4d ago
Newsfilter
argenx SE Q4 Earnings Beat Expectations with Strong Revenue Growth
4d ago
seekingalpha
argenx Reports $4.2 Billion in 2025 Net Sales, Achieving First Year of Profitability
4d ago
Newsfilter
argenx Reports Positive Results for VYVGART in Ocular Myasthenia Gravis Treatment
4d ago
Newsfilter
argenx SE to Announce Q4 Earnings on February 26
5d ago
seekingalpha
Show More News
ARGX Events
No data
ARGX Monitor News
argenx Reports Strong Q4 Earnings and Future Growth Plans
Feb 26 2026
argenx SE reaches 20-day high amid market gains
Jan 27 2026
argenx SE transitions leadership amid market strength
Jan 05 2026
argenx discontinues Phase 3 TED studies, shares decline
Dec 15 2025
ARGX Earnings Analysis
Argenx SE Earnings: Immunology Innovations Drive Growth- Intellectia AI™
4 months ago
argenx SE 2024: Earnings Growth & Strategic Advancements- Intellectia AI™
1 years ago
People Also Watch
